08008600178

  Home    |    About Us    |    HouseCalls    |    Treatment Prices    |    Contact Us     

1-7 Harley Street, London

info@cosmedocs.co.uk

   At CosMedocs we specialise in non-surgical cosmetic treatments that produce rapid results at affordable prices ensuring that looking younger is not only for celebrities. 

CosMedocs

    your cosmetic doctor, not clinic!

London Botox Treatments

Special Offers For Botox Injections:
2 Area / £160

3 Area / £240

Also see lip filler treatments - £500 for complete lip & peri-oral treatment

Further Information

History Of Botulinum Toxin

It may surprise you to know that botulinum toxin, or Botox® as we commonly now call it, has a history stretching back almost two hundred years. In 1822, a German doctor named Justinius Kerner, suggested that botulinum toxin injections might be used in the treatment of excessive sweating or hyperhidrosis. Botox® is now regularly used for this condition.

By the late 1960s, Botox® had begun to be used in American clinics for the treatment of squints (strabismus). Its use in treatment of the eyes was pioneered by an American called Alan Scott. Twenty years later, the real breakthrough came in the wider application of Botox® when Allergan, the American manufacturer of Botox®, was granted approval to market the drug by the Federal Drugs Agency. This gave Allergan the license to sell its new product throughout the U.S. Since then, Botox® has been registered and used in over 90 countries around the world, and two other versions of botulinum toxin have also been developed and marketed, namely Dsyport® and Neurobloc®.

The next significant development in knowledge about botulinum toxin came in 1987 via a Canadian Ophthalmologist, Dr. Jean Carruthers. She had been treating her patients who suffered from blepharospasm with Botox®. Dr. Carruthers observed that a "side-effect" of this treatment was the reduction of crow's feet and wrinkles around the eyes. She then decided to test these findings scientifically, and she and her husband, a Consultant Dermatologist, (skin specialist) devised clinical trials to monitor the effectiveness of this treatment.

Since then, an enormous amount of clinical trial work and patient experience has been established using Botox® for the treatment of wrinkles, and in 2006, The American Society for Aesthetic Plastic Surgery rated treatment with botulinum toxin the most popular aesthetic procedure in the U.S..

A staggering 3.18 million Americans had a Botox® treatment in 2006, an increase of 3% on 2005 figures. This represents 27.8% of all cosmetic treatments in the U.S. in that year.  Although there are as yet no similar detailed statistics available for the United Kingdom, it is likely that Botox® is also the number one procedure here.

Botox® is now licensed by the regulatory authorities in the U.S., as well as more than a dozen other countries around the world, for the treatment of glabellar lines and wrinkles.

Upper Face Areas (Each Label = 1 Area)

n March 2006, Vistabel®, the brand name used for Botox® with a dosing specific to treat glabellar lines was granted a licence in the UK from the Medicines and Healthcare products Regulatory Agency (MHRA) for the "temporary improvement in the appearance of moderate to severe glabellar lines (vertical 'frown' lines between the eyebrows) in adult women and men aged 65 and younger, when the severity of these lines has a psychological impact for the patie

Backaches

Preliminary studies have suggested that, in patients who do not find relief from traditional pain medication, Botox® injections are safe and provide local relief of low back pain without systemic side effects (unlike central nervous system side effects seen with other more traditional pain treatments). In a small randomized trial of 31 adults with low back pain lasting longer than 6 months, 73% of participants who received injections reported significant pain relief after 3 weeks (Foster 2001). More studies—especially larger, randomized trials—are necessary to further evaluate the use of Botox®. Although there was initially concern that large doses repeatedly injected into the spinal muscles could lead to muscle weakness, this occurrence has not been noted in any studies (Difazio 2002; Wheeler 1998).

Headaches & Migranes

MIGRAINES: Studies in the treatment of migraine have shown a decrease in the incidence and severity of headaches for a period of 3 to 4 months after injection of Botox®, along with a reduction in the use of pain killers (Barrientos 2002; Mauskop 2002). Some people respond well after only a single treatment session, while others improve after repeated injections (Binder 2000; Silberstein 2000; Mathew 2002). Some physicians believe that Botox® may even change or halt the course of headaches (Mathew 2002).

TENSION HEADACHES: The efficacy of Botox® in the treatment of chronic tension headaches is under debate. Some studies suggest positive benefits (Relja 1998; Schulte-Mattler 1999; Smuts 1999; Freund 2000).  A recent study analyzed the results of 271 patients with chronic daily headaches, tension headaches, or migraines, and found that Botox® injections decreased the frequency of all headaches by more than a half(Blumenfeld 2003). Overall, 85.6% of study participants claimed their symptoms improved. Temporary eyelid or eyebrow drooping was each reported by three people; other side effects were minimal.

Excessive Sweating

Hyperhidrosis is a chronic disorder of excessive sweating that can affect any body part, including the underarms, the palms, the soles of the feet, and the face.

The efficacy and patient satisfaction of Botox® is considered to be excellent. Until now, most treatments for excessive sweating were often ineffective, short acting or had significant risks. For those suffering from excessive sweating, Botox® treatments give them new hope where previous therapies have failed before.

Botox® treatment for excessive sweating was approved in the United Kingdom in July 2001.

By blocking the release of acetylcholine, which activates the sweat glands, Botulinum injections can relieve excessive sweating, a life-altering procedure for those suffering from the embarrassing ailment, and were approved for use under the arm in September 2001.

Botox for Dystonias (Muscle Disoders)

Some muscle twitching disorders are due overactive muscle contractions that are not voluntary.  These are easily treated with Botox which acts to temporarily stop these extra muscle (muscle parts) from contacting